Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 315-318 , April 2010

Dietary fatty acids and arthritis

  • S. Hurst

      Affiliations

    • Current address: School of Medicine, Cardiff University, Cardiff CF14 4XN, Wales, UK.
  • ,
  • Z. Zainal

      Affiliations

    • Current address: Malaysian Palm Oil Board, Persairan Institusi, 4300 Kajang, Selangor, Malaysia.
  • ,
  • B. Caterson
  • ,
  • C.E. Hughes
  • ,
  • J.L. Harwood

      Affiliations

    • Corresponding Author InformationCorresponding author.

References 

  1. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Br. World Health Organ. 2003;81:646–656
  2. Rayman M, Callaghan A. Nutrition and Arthritis. Oxford: Blackwell Publishers; 2006;
  3. West SG. Rheumatology Secrets. 2nd ed.. Philadelphia: Hanley and Belfus; 2002;
  4. Symmons D, Turner G, Webb R, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology. 2002;41:793–800
  5. Percival T. Observations on the medical uses of the Oleum Jecons Aselli, or cod liver oil, in the chronic rheumatism and other painful disorders. London Med. J. 1783;3:393–401
  6. Horrobin DF. Low prevalences of coronary heart disease, psoriasis, asthma and rheumatoid arthritis in Eskimos. Med. Hypotheses. 1987;22:421–428
  7. James MJ, Proudmann SM, Cleland IG. Dietary n-3 fats as an adjunct therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis. Prostaglandins Leukot. Essent. Fatty Acids. 2003;68:399–405
  8. Ariza-Ariza R, Mestanza-Peralta M, Cardiel MH. Omega-3 fatty acids in rheumatoid arthritis: an overview. Semin. Arthritis Rheum. 1998;27:366–370
  9. Calder PC, Zurier AB. Polyunsaturated fatty acids and rheumatoid arthritis. Curr. Opin. Clin. Nutr. 2001;14:115–121
  10. Darlington IG, Stone TW. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br. J. Nutr. 2001;85:851–869
  11. Kremer JM. n-3 Fatty acid supplements in rheumatoid arthritis. Am. J. Clin. Nutr. 2000;71:349S–351S
  12. Cunnane SC. Problems with essential fatty acids: time for a new paradigm?. Prog. Lipid Res. 2003;42:544–568
  13. Kremer JM, Bigauotte J, Michalek AV, et al. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet. 1985;1:184–187
  14. Kremer JM, Jubiz W, Michalek A, et al. Fish oil fatty acid supplementation in active arthritis. Ann. Intern. Med. 1987;106:497–503
  15. Sperling RI, Weinblatt M, Robin J, et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum. 1987;30:988–997
  16. Cleland LG, French J, Betts HW, et al. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J. Rheumatol. 1988;15:1471–1475
  17. Kremer J, Lawrence D, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis: clinical and immunological effects. Arthritis Rheum. 1990;33:810–820
  18. van der Temple H, Tulleken J, Limburg P, et al. Effects of fish oil supplementation in rheumatoid arthritis. Ann. Rheum. Dis. 1990;49:76–80
  19. Skoldstam L, Borjeddon O, Kjallman A, et al. Effect of 6 months of fish oil supplementation in stable rheumatoid arthritis. A double blind, controlled study. Scand. J. Rheumatol. 1992;21:178–185
  20. Nielsen GL, Farrvang KL, Thomsen BS, et al. The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomised double blind trial. Eur. J. Clin. Invest. 1992;22:687–691
  21. Lau CS, Morley KD, Belch JJF. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis—a double-blind placebo-controlled study. Br. J. Rheumatol. 1993;32:982–989
  22. Guesens P, Wouters C, Nijs J, et al. Long term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis Rheum. 1994;37:824–829
  23. Fortin PR, Lew RA, Liang MH, et al. Validation of a meta-analysis. The effects of fish oil in rheumatoid arthritis. J. Clin. Epidemiol. 1995;48:1379–1390
  24. C.H. Maclean, W.A. Mojica, S.C. Morton, et al., Effects of omega-3 fatty acids on lipids and glycemic control in Type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus and osteoporosis, AHRQ Publication No. 04-E012-1, Agency for Healthcare Research and Quality, Rockville, MD, USA, 2004.
  25. Berbert A, Kondo C, Almendra C, et al. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition. 2005;21:131–136
  26. James MJ, Gibson R, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator protection. Am. J. Clin. Nutr. 2000;71:343S–348S
  27. Grimble RF, Howell WM, O’Reilly G, et al. The ability of fish oil to suppress tumour necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumour necrosis factor alpha production. Am. J. Clin. Nutr. 2002;76:454–459
  28. Yaqoob P. Lipids and the immune response: from molecular mechanisms to clinical applications. Curr. Opin. Clin. Nutr. 2003;6:133–150
  29. Volker D, Fitzgerald P, Major G, et al. Effect of fish oil concentrate in the treatment of rheumatoid arthritis. J. Rheumatol. 2000;27:2343–2346
  30. Adam O, Beringer C, Kless T, et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol. Int. 2003;23:27–36
  31. Sundrarjun T, Komindr S, Archararit N, et al. Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis. J. Int. Med. Res. 2004;32:443–454
  32. Caterson B, Flannery CR, Curtis CE, et al. Mechanisms involved in cartilage proteoglycan metabolism. Matrix Biol. 2000;19:333–344
  33. Little CB, Hughes CE, Curtis CL, et al. Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation. Matrix Biol. 2002;21:271–288
  34. Zainal Z, Longman AJ, Hurst S, et al. Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthr. Cartilage. 2009;17:882–891
  35. Zainal Z, Longman AJ, Hurst S, et al. Modification of palm oil for anti-inflammatory nutraceutical properties. Lipids. 2009;44:581–592
  36. S. Hurst, S.G. Rees, P.F. Randerson et al., Contrasting effects of n-3 and n-6 fatty acids on cyclooxygenase-2 in model systems for arthritis. Lipids 44 (2009) 889–896.

PII: S0952-3278(10)00052-9

doi: 10.1016/j.plefa.2010.02.008

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 315-318 , April 2010